Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Astrocytoma (Phase 1)
Autoimmune Diseases (Early Phase 1)
Brain Neoplasms (Phase 1)
Central Nervous System Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Gliosarcoma (Phase 1)
Hamartoma (Phase 1/Phase 2)
Healthy Volunteers (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Malaria, Falciparum (Phase 1/Phase 2)
Melanoma (Phase 2)
Mesothelioma, Malignant (Phase 2)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Oligodendroglioma (Phase 1)
Ovarian Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue